PIPELINE

MORE
EUPHOL, INGENOL B AND INGENOL C
Optogenetics for Cardiac Pacing and Resynchronization
EMMPRIN vaccination: a novel strategy to inhibit tumor progression and metastasis
CXCL11-Ig as potential drug for autoimmunity and GVHD
FR-Semaphorin-3C as a novel therapeutic for oncology and ophthalmology
IL-31-IgG, a novel immune modulatory agent with combinatorial anti-tumor properties
A furin cleavage resistant semaphorin 3E mutant as a potential anti-angiogenic agen..
KPC1‐mediated ubiquitination and proteasomal processing of NF‐κB1 p105 to p50
IVMED 50 (Macular Degeneration)

GLOBAL C&D PROJECT PARTICIPANTS




    • Aagami
    • Bionaturis
    • Allovate
    • Cellmid
    • Amorchem
    • Crossbeta Biosciences
    • Aurigene
    • Intrommune Therapeutics
    • Kissei Pharmaceutical
    • MyeloRx
    • Genefrontier
    • Coarebiotech
    • Immune Biosolutions
    • NEOMED
    • APIM Therapeutics
    • Ulster University
    • Southern Research
    • UCL
    • Atrin Pharmaceuticals
    • LTTO
    • AVEO Pharmaceuticals
    • ULB
    • Amunix
    • University of Namur
    • iVeena
    • Valin Technologies
    • MBM Sciencebridge
    • Wiborg
    • Aronora, Inc.
    • Lipopharma
    • Aeterna Zentaris
    • cancer research technology
    • yissum
    • yeda